Grünwald, 82031,
Germany
Dermapharm Germany Technographics
Dermapharm Germany Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Dermapharm Germany and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 3551 Dermapharm Germany employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Dermapharm Germany has purchased the following applications: Insightsoftware IDL Publisher for Financial Consolidation and Close in 2018, Matomo Analytics for Marketing Analytics in 2018, Microsoft 365 for Collaboration in 2025 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Dermapharm Germany is running and its propensity to invest more and deepen its relationship with Insightsoftware , Matomo , HubSpot or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Dermapharm Germany revenues, which have grown to $1.37 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Dermapharm Germany intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Dermapharm Germany Tech Stack and Enterprise Applications
Dermapharm Germany EPM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Insightsoftware | Legacy | Insightsoftware IDL Publisher | Financial Consolidation and Close | EPM | n/a | 2018 | 2018 |
In 2018, Dermapharm Germany implemented Insightsoftware IDL Publisher alongside IDL Konsis to support IFRS consolidation and to prepare for its 2018 IPO, aligning workstreams under a Financial Consolidation and Close initiative. The implementation focused on strengthening external and management reporting processes within the German finance organization.
Implementation covered core consolidation capabilities typical of Financial Consolidation and Close systems, using IDL Konsis for consolidated data aggregation and consolidation logic, and Insightsoftware IDL Publisher for automated notes and external report generation. Insightsoftware IDL Publisher was configured to produce statutory notes and structured external reports, standardize disclosure templates, and streamline assembly of IFRS reporting packages.
Operational scope emphasized finance and accounting functions responsible for period close, statutory reporting, and investor filing readiness as part of IPO preparation, with rollout centered on German reporting entities and group consolidation workflows. The deployment was positioned to make close processes more audit friendly and to shorten the window for producing management packs and regulatory submissions.
Governance changes targeted tighter control over disclosure assembly and sign off, with process orchestration between consolidation runs and report publishing to ensure on time regulatory reporting. The case study reports faster, audit friendly close processes and on time regulatory reporting as explicit outcomes following the Insightsoftware IDL Publisher implementation.
|
Dermapharm Germany CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Matomo | Legacy | Matomo Analytics | Marketing Analytics | CRM | n/a | 2018 | 2018 |
|
|
|
|
|
Marketing Automation | CRM |
|
2025 | 2025 |
|
|
|
|
|
Marketing Automation | CRM |
|
2025 | 2025 |
|
|
|
|
|
Tag Management | CRM |
|
2025 | 2025 |
|
Dermapharm Germany Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2025 | 2025 |
|
|
|
|
|
Collaboration | Collaboration |
|
2025 | 2025 |
|
Dermapharm Germany Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Digital Signing | Content Management |
|
2025 | 2025 |
|
|
|
|
|
Web Content Management | Content Management |
|
2018 | 2018 |
|
|
|
|
|
Web Content Management | Content Management |
|
2025 | 2025 |
|
Dermapharm Germany ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Remote Monitoring and Management | ITSM |
|
2025 | 2025 |
|
Dermapharm Germany TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2025 | 2025 |
|
Dermapharm Germany IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2025 | 2025 |
|
|
|
|
|
Domain Name System (DNS) | IaaS |
|
2022 | 2022 |
|
Dermapharm Germany CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Security (AppSec) | CyberSecurity |
|
2025 | 2025 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2018 | 2018 |
|
|
|
|
|
Secure Sockets Layer (SSL) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Dermapharm Germany
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Dermapharm Germany Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||